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Background:
In patients with unstable angina, elevated C-reactive protein (CRP) has been shown to predict recurrent coronary events. However, little data is available on the prognostic value of CRP in acute myocardial infarction (AMI), and its relation to measures of infarct size.
Methods: CRP was measured within 24-h of symptoms onset in a prospective series of 348 consecutive patients (mean age 62 + 13 y, men -76%) with AMI (260 with ST-elevation AMI). Echocardiographic examination was performed on day 2 or 3. Thirty-day mortality was evaluated using Cox proportional-hazards model wtth the following covariates: age, gender, prior aspirin use, Killip class, diabetes, peak CK. SBP < 100 mm Hg, echocardiographic wall motion score index (WMSI Background: Hyponatremia (HNa) is recognized as a predictor of adverse outcome in hospitalized patients (pts), especially in pts with heart failure. However, little is known about the prevalence and prognostic significance of HNa in pts with acute ST-elevation myocardial infarctjon (STEMI).
Methods:
We studied 706 consecutive pts (age 62 f 13, 75% male) with STEMI. Plasma sodium (Na) was measured on admission and at 24,46, and 72 hours thereafter. go-day mortality was evaluated using Cox proportional-hazards model, adjusting for important covariates including age, gender, diabetes, Killip class, peak CK, diuretic therapy, reperfusion therapy (thrombolysis or primary angioplasty), ejection fraction, heart rate > 100, and svstolic blood oressure < 100 mm Ha on admission.
Rest&: HNa (N&l35 mmol/L) developed during the first 72-h of hospital stay in 53% of Dts. Na decreased to 126.130 mmol/L in 29 ots and to<125 mmollL in 7 ots. Althouoh pti receiving diuretics developed HNa more commonly compared to pts who were not (64% vs. 46%, p < O.OOOl), the majority of pts (66%) who developed HNa were not receiving diuretics. Kaplan-Meyer survival curves indicated that pts who developed HNa were at increased risk of go-day mortality ( Figure) . In a Cox multivariate analysis, HNa remained a significant and independent predictor of go-day mortality (RR 3.0, 95% Cl 1.3-6.5, p = 0.006). Chest paln is one of the most common reasons for emergency department (ED) visits in the US, accounting for about 6% of all visits. Identifying the etiology of chest pain is challenging and resource-intensive. Although Ml can be diagnosed using sensitive cardiac injury markers, currently no such marker is available for diagnosing ischemia. ED diagnosis is based on the physician's clinical judgment using findings from the history, clinical exam, and diagnostic tests including the ECG and rest myocardial perfusion imaging (MPI). However, idenhfication is limited by the sub-optimal sensibvity of the ECG. Although MPI has higher sensitivity and negative predictive value (NPV), it is not wdely used due to its cost and complexity.
lschemla Modified Albumin (IMATM) is produced when circulating albumin comes in contact with ischemic myocardium. IMA increases with ischemia and is detectable in serum prior to necrosis markers. IMA utility and diagnostic accuracy compared to traditional methods for diagnosing myocardial ischemia in the ED has not been well described.
We are currently enrolling patients (pts)(target = 400) presenting to the ED with acute chest pain. Pts undergo rest MPI with either ongoing symptoms or within 1 hour of pain cessation. The ED ECG is recorded and serial sampling of IMA before and after rest MPI is performed. Diagnosis of ischemia is determined by expert cardiologists blinded to IMA values using all clinical data collected at presentation and during routine follow-up. Results: Data from the first 127 patents was available for analysis; 54 males, 73 females; mean age 52 years (30-96). Final diagnosis was 14 positive and 113 negative for &hernia. Sensitivity of IMA (cutoff 85 UlmL), ECG, and MPI for ischemia was 71%, 21%, and 69%, respectively.
NPV of IMA, ECG, and MPI was 90%, 91%, and 96%, respectively. Adding the ECG to IMA did not improve sensitivity over IMA alone, but combining results from IMA and MPI produced a sensitivity and NPV of 100% Conclusions: These preliminary results suggest that IMA improves the ability to diagnose myocardial &hernia in pts presenting to the ED with acute chest pain. Quantifying subtle myocardial injury IS now routine, however, early detection of myocardial &hernia using serum biomarkers remains elusive. lschemia modified albumin@ (IMA) is a promising new blood test for detection of ischemia. We studied IMA in the setting of percutaneous coronary intervention (PCI) as a model of known transient ischemla.
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Early Detection of Myocardial lschemia by a Novel
Methods:
Eleven patients (pts) (age 60+1 I, 7 males) without evidence of ischemia for > 7 days undergoing single-vessel PCI (6 RCA and 3 LAD) were enrolled. Blood was collected: pre-PCI after arterial access, <IO minutes post initial balloon inflation (post-lnfl), and 2.6, 9, 12. 16 hours (hr) post-PCI. Samples were tested for IMA, troponin T and CK-
MB.
Results: All patients had successful PCI, with mean longest and total balloon inflation times of 2.5+1 .I and 4.321.9 minutes, respectively. Pre-PCI mean IMA levels (95.4*7.2 UlmL) increased in IO of 11 pts post-lnfl (104.9ilO.9 UlmL. P<O.OOl versus pre-PCI) (Figure) . IMA levels post-PC1 at 2 hr (97.6+11.4 U/mL), 6 hr (91.0+12.2 UlmL), 9 hr, 12 hr and 16 hr were not significantly different from pre-PCI. Seven patients had ECG or echocardiographic evidence of ischemia with PCI, while 2 had post-PC1 injury measured by troponin T or CK-MB.
